EcoDrugPlus

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSSTUG00000028501
Gene Symbol: LOC115153372
3 Cross references
220 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSSTUG00000024257
Gene Symbol: LOC115193564
3 Cross references
219 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSSTUG00000011238
Gene Symbol: AVPR1A
3 Cross references
139 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSSTUG00000005970
Gene Symbol: AVPR1A
3 Cross references
187 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSSTUG00000006275
Gene Symbol: AVPR1A
3 Cross references
139 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSSTUG00000016474
Gene Symbol: AVPR2
3 Cross references
172 Possible Orthologues:

Aromatase-Like

Ensembl ID : ENSSTUG00000030814
Gene Symbol: LOC115203363
3 Cross references
248 Possible Orthologues:

Aromatase-Like

Ensembl ID : ENSSTUG00000020100
Gene Symbol: LOC115166948
3 Cross references
248 Possible Orthologues:

Aryl Hydrocarbon Receptor-Like

Ensembl ID : ENSSTUG00000029214
Gene Symbol: LOC115182396
3 Cross references
152 Possible Orthologues:

Aryl Hydrocarbon Receptor-Like

Ensembl ID : ENSSTUG00000027876
Gene Symbol: LOC115186368
3 Cross references
152 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSSTUG00000038127
Gene Symbol: LOC115173623
3 Cross references
187 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSSTUG00000015189
Gene Symbol: LOC115175842
3 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).